---
title: Clarithromycin + Lansoprazole + Tinidazole
description: >-
  This triple therapy is primarily prescribed for the eradication of
  *Helicobacter pylori* associated with peptic ulcer disease (gastric and
  duodenal ulcers) and active chronic gastritis.
is_banned: false
lastModified: '2025-09-22T17:22:08.815Z'
faqs:
  - q: >-
      What is the recommended dosage for Clarithromycin + Lansoprazole +
      Tinidazole?**


      **A:** Adults: Lansoprazole 30mg, Clarithromycin 250mg, and Tinidazole
      500mg twice daily (morning and evening) for 7 days.  Not recommended for
      children under 12.
    a: >-
      A:** Adults: Lansoprazole 30mg, Clarithromycin 250mg, and Tinidazole 500mg
      twice daily (morning and evening) for 7 days.  Not recommended for
      children under 12.
  - q: >-
      What are the most common side effects?**


      **A:** Nausea, diarrhea, abdominal pain, headache, and metallic taste
      disturbance are common.
    a: >-
      A:** Nausea, diarrhea, abdominal pain, headache, and metallic taste
      disturbance are common.
  - q: |-
      Can this combination be used during pregnancy or breastfeeding?**

      **A:** No, it's contraindicated during pregnancy and breastfeeding.
    a: 'A:** No, it''s contraindicated during pregnancy and breastfeeding.'
  - q: >-
      What are the major drug interactions to be aware of?**


      **A:** Clarithromycin inhibits CYP3A4, leading to potential interactions
      with numerous drugs (e.g., warfarin, statins).  Consult a drug interaction
      database for a comprehensive list.
    a: >-
      A:** Clarithromycin inhibits CYP3A4, leading to potential interactions
      with numerous drugs (e.g., warfarin, statins).  Consult a drug interaction
      database for a comprehensive list.
  - q: >-
      What is the mechanism of action of this triple therapy?**


      **A:** It combines a proton pump inhibitor (Lansoprazole), a macrolide
      antibiotic (Clarithromycin), and a nitroimidazole
      antibacterial/antiprotozoal agent (Tinidazole) to eradicate *H. pylori*.
    a: >-
      A:** It combines a proton pump inhibitor (Lansoprazole), a macrolide
      antibiotic (Clarithromycin), and a nitroimidazole
      antibacterial/antiprotozoal agent (Tinidazole) to eradicate *H. pylori*.
  - q: >-
      What are the indications for using this combination?**


      **A:** Primarily for *H. pylori* eradication associated with peptic ulcer
      disease and active chronic gastritis.
    a: >-
      A:** Primarily for *H. pylori* eradication associated with peptic ulcer
      disease and active chronic gastritis.
  - q: >-
      Are there any dietary restrictions while taking this medication?**


      **A:** Patients should avoid alcohol during Tinidazole therapy and for
      three days after the last dose due to the potential for a disulfiram-like
      reaction.
    a: >-
      A:** Patients should avoid alcohol during Tinidazole therapy and for three
      days after the last dose due to the potential for a disulfiram-like
      reaction.
  - q: >-
      What should be done in case of a missed dose?**


      **A:** Take the missed dose as soon as you remember, unless it is almost
      time for the next dose.  Do not double the dose.
    a: >-
      A:** Take the missed dose as soon as you remember, unless it is almost
      time for the next dose.  Do not double the dose.
  - q: >-
      What are the signs of a serious adverse reaction?**


      **A:** Severe allergic reactions (rash, itching, swelling, difficulty
      breathing), jaundice, dark urine, severe abdominal pain, irregular
      heartbeat, and persistent vomiting or diarrhea are signs of serious
      adverse reactions and warrant immediate medical attention.
    a: >-
      A:** Severe allergic reactions (rash, itching, swelling, difficulty
      breathing), jaundice, dark urine, severe abdominal pain, irregular
      heartbeat, and persistent vomiting or diarrhea are signs of serious
      adverse reactions and warrant immediate medical attention.
---
## **Usage**

This triple therapy is primarily prescribed for the eradication of *Helicobacter pylori* associated with peptic ulcer disease (gastric and duodenal ulcers) and active chronic gastritis.

**Pharmacological Classification:**

* **Clarithromycin:** Macrolide antibiotic
* **Lansoprazole:** Proton pump inhibitor (PPI)
* **Tinidazole:** Antiprotozoal and antibacterial agent (nitroimidazole derivative)

**Mechanism of Action:**  This combination targets *H. pylori* through multiple mechanisms. Clarithromycin inhibits bacterial protein synthesis, Lansoprazole suppresses gastric acid secretion, and Tinidazole disrupts bacterial DNA synthesis. The reduced acidity creates an environment less conducive to *H. pylori* survival, enhancing the efficacy of the antibiotics.

## **Alternate Names**

While the generic name is Clarithromycin + Lansoprazole + Tinidazole, several brand names exist depending on the region and manufacturer.  These include Pylokit, LCT Kit, Gastro Kit, and Baylokit.


## **How It Works**

**Pharmacodynamics:**

* **Clarithromycin:**  Binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis.
* **Lansoprazole:**  Irreversibly inhibits H+/K+-ATPase (proton pump) in gastric parietal cells, reducing gastric acid secretion.
* **Tinidazole:**  Enters the microbial cell and forms cytotoxic metabolites which damage bacterial DNA, leading to cell death.

**Pharmacokinetics:**

* **Clarithromycin:**  Well-absorbed orally, metabolized in the liver, and excreted in urine and feces.  Can increase serum concentrations of other drugs by inhibiting CYP450 enzymes (particularly CYP3A4).
* **Lansoprazole:**  Rapidly absorbed orally, extensively metabolized by the liver (CYP2C19 and CYP3A4), and excreted in urine and feces.
* **Tinidazole:**  Well-absorbed orally, partially metabolized in the liver, and excreted primarily in the urine.

**Receptor Binding, Enzyme Inhibition, or Neurotransmitter Modulation:**

* Clarithromycin: 50S ribosomal subunit binding.
* Lansoprazole: H+/K+-ATPase inhibition.
* Tinidazole:  DNA damage through reduction of the nitro group.

**Elimination Pathways:**

* Clarithromycin: Hepatic metabolism, renal and fecal excretion.
* Lansoprazole: Hepatic metabolism (CYP2C19 and CYP3A4), renal and fecal excretion.
* Tinidazole: Primarily renal excretion, partially hepatic metabolism.


## **Dosage**


### **Standard Dosage**

#### **Adults:**  One capsule of Lansoprazole (30 mg), one tablet of Tinidazole (500 mg), and one tablet of Clarithromycin (250 mg) are taken twice daily (morning and evening) for 7 days.

#### **Children:** This combination is not recommended for children under 12 years of age.  Safety and efficacy have not been established in this population.


#### **Special Cases:**

* **Elderly Patients:** Dosage adjustments may be necessary depending on renal and hepatic function.
* **Patients with Renal Impairment:** Dose modification may be required based on creatinine clearance.
* **Patients with Hepatic Dysfunction:** Dosage adjustment is advisable in patients with severe hepatic impairment.
* **Patients with Comorbid Conditions:** Careful consideration and potential dose adjustments are necessary for patients with certain comorbid conditions like heart disease, diabetes, and those taking other medications.


### **Clinical Use Cases**

This specific drug combination is not typically used in settings like intubation, surgical procedures, mechanical ventilation, ICU, or emergency situations. It's primarily indicated for *H. pylori* eradication in the context of peptic ulcer disease and chronic gastritis.


### **Dosage Adjustments**

Dose adjustments are necessary based on patient-specific factors, including renal/hepatic dysfunction and potential drug interactions. Therapeutic drug monitoring may be considered in certain situations.


## **Side Effects**


### **Common Side Effects:**

Nausea, diarrhea, abdominal pain, headache, metallic taste disturbance, and altered liver function tests.


### **Rare but Serious Side Effects:**

Severe allergic reactions (anaphylaxis, angioedema), hepatotoxicity, cardiac arrhythmias (including QT prolongation), *Clostridium difficile* infection (pseudomembranous colitis), and blood dyscrasias.

### **Long-Term Effects:**

Hypomagnesemia, vitamin B12 deficiency, and increased risk of bone fractures with prolonged use of PPIs.

### **Adverse Drug Reactions (ADR):**

Any signs of hypersensitivity, severe gastrointestinal issues, cardiac arrhythmias, or signs of neurotoxicity require immediate intervention.


## **Contraindications**

Hypersensitivity to any component of the combination, concurrent use of cisapride, pimozide, astemizole, terfenadine, ergotamine, or dihydroergotamine (due to interactions with Clarithromycin), concurrent use of atazanavir or rilpivirine (due to interactions with Lansoprazole), pregnancy (especially the first trimester), and porphyria.


## **Drug Interactions**

This combination has numerous potential drug interactions.  Clarithromycin is a CYP3A4 inhibitor and can increase the concentrations of drugs metabolized by this enzyme (e.g., warfarin, statins, some antiepileptics). Lansoprazole can interact with drugs like tacrolimus, clopidogrel, and methotrexate.  Tinidazole can have a disulfiram-like reaction with alcohol.  Concurrent use of antacids may reduce the absorption of Lansoprazole. Consult comprehensive drug interaction resources for detailed information.


## **Pregnancy and Breastfeeding**

This combination is contraindicated during pregnancy, particularly in the first trimester, and breastfeeding should be avoided during treatment and for 3 days after the last dose of Tinidazole.


## **Drug Profile Summary**

* **Mechanism of Action:**  Eradication of *H. pylori* by suppressing gastric acid secretion and inhibiting bacterial protein and DNA synthesis.
* **Side Effects:** Nausea, diarrhea, abdominal pain, headache, metallic taste, and rarely, severe allergic reactions, hepatotoxicity, or cardiac arrhythmias.
* **Contraindications:** Hypersensitivity, concurrent use of specific drugs (e.g., cisapride, pimozide), pregnancy, and breastfeeding.
* **Drug Interactions:** Numerous, particularly with CYP3A4 substrates, due to Clarithromycin's inhibitory effect.
* **Pregnancy & Breastfeeding:** Contraindicated.
* **Dosage:** Adults: Lansoprazole 30 mg, Tinidazole 500 mg, and Clarithromycin 250 mg twice daily for 7 days.  Not recommended for children under 12.
* **Monitoring Parameters:** Liver function tests, complete blood count, and signs of adverse effects.

## **Popular Combinations**

This combination itself is a standard and popular regimen for *H. pylori* eradication.


## **Precautions**

Assess for allergies, hepatic and renal function, and concomitant medications before initiating therapy.  Advise patients to avoid alcohol during and for 3 days after Tinidazole treatment. Counsel on potential side effects and drug interactions. Monitor for adverse events.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Clarithromycin + Lansoprazole + Tinidazole?**

**A:** Adults: Lansoprazole 30mg, Clarithromycin 250mg, and Tinidazole 500mg twice daily (morning and evening) for 7 days.  Not recommended for children under 12.

### **Q2: What are the most common side effects?**

**A:** Nausea, diarrhea, abdominal pain, headache, and metallic taste disturbance are common.

### **Q3: Can this combination be used during pregnancy or breastfeeding?**

**A:** No, it's contraindicated during pregnancy and breastfeeding.

### **Q4: What are the major drug interactions to be aware of?**

**A:** Clarithromycin inhibits CYP3A4, leading to potential interactions with numerous drugs (e.g., warfarin, statins).  Consult a drug interaction database for a comprehensive list.

### **Q5: What is the mechanism of action of this triple therapy?**

**A:** It combines a proton pump inhibitor (Lansoprazole), a macrolide antibiotic (Clarithromycin), and a nitroimidazole antibacterial/antiprotozoal agent (Tinidazole) to eradicate *H. pylori*.


### **Q6:  What are the indications for using this combination?**

**A:** Primarily for *H. pylori* eradication associated with peptic ulcer disease and active chronic gastritis.

### **Q7: Are there any dietary restrictions while taking this medication?**

**A:** Patients should avoid alcohol during Tinidazole therapy and for three days after the last dose due to the potential for a disulfiram-like reaction.

### **Q8:  What should be done in case of a missed dose?**

**A:** Take the missed dose as soon as you remember, unless it is almost time for the next dose.  Do not double the dose.

### **Q9: What are the signs of a serious adverse reaction?**

**A:** Severe allergic reactions (rash, itching, swelling, difficulty breathing), jaundice, dark urine, severe abdominal pain, irregular heartbeat, and persistent vomiting or diarrhea are signs of serious adverse reactions and warrant immediate medical attention.

